Cisen Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cisen Pharmaceutical Co Ltd with three other
companies in this sector in CHINA :
SSY Group Ltd
sales of 4.08 billion Chinese Renmimbi [US$572.19 million]
of which 97%
was Intravenous Infusion Solution and Others),
Guangdong Taiantang Pharmaceutical Co Ltd
(4.01 billion Chinese Renmimbi [US$562.42 million]
of which 81%
was Medicine Wholesale & Retail), and
Haisco Pharmaceutical Group Co Ltd
(3.94 billion Chinese Renmimbi [US$551.82 million]
of which 100%
was Pharmaceutical Industry).
Cisen Pharmaceutical Co Ltd reported sales of 4.11 billion Chinese Renmimbi (US$575.81 million)
December of 2019.
increase of 8.0%
versus 2018, when the company's sales were 3.80 billion Chinese Renmimbi.
Sales at Cisen Pharmaceutical Co Ltd have increased during each of the previous five years
(and since 2014, sales have increased a total of 72%).
Sales of Others saw an increase
that was more than double the company's growth rate: sales were up
60.9% in 2019, from
101.08 million Chinese Renmimbi to 162.65 million Chinese Renmimbi.